About ConsumerLab.com

Posted January 12, 2021

FDA Warns Seller of Turmeric, Ashwagandha, Glucosamine, and More

On December 18, 2020, the FDA issued a warning letter to Reddy Naturals following a review of the company's website, which found statements made about the company's products Glycostasis, Glucosamine Curcumin, Turmeric 50, Turmeric Curcumin, Cetyl Curcumin, Ashwagandha, Huruli, Black Seed Oil, Curcumin Turmerone, and Ashwagandha Honey to be drug claims.

For example, Turmeric Curcumin was promoted with statements such as "Our honey flavored Reddy Naturals Turmeric Curcumin with black pepper aids in reducing inflammation, joint and body pains."

See ConsumerLab's Turmeric and Curcumin Supplements and Spices Review for tests of related products.

Glucosamine Curcumin was promoted with statements such as "Reduces joint pain, swelling, and fatigue."

See ConsumerLab's Joint Health Supplements Review (Glucosamine, Chondroitin, MSM and Boswellia) for tests of related products.

Ashwagandha was promoted with statements such as "Stabilizes blood sugar" and "Lowers cholesterol levels."

See ConsumerLab's Ashwagandha Supplements Review for tests of related products.

Black Seed Oil was promoted with statements such as "Reduces flu, fever, cough, and asthma" and "May help reduce blood sugar and cholesterol levels."

See ConsumerLab's Answer to the question, What are the health benefits of black cumin seed (black seed) oil? for more information.

In addition, the products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

For more information, use the link below.

Warning Letter: Reddy Naturals

See related warnings:

FDA Warns Seller of Evening Primrose Oil and Beta Glucan

FDA Warns Seller of Curcumin and Cholesterol Supplements

FDA Warns Immusist for Drug Claims

FDA Warns Seller of Digestive Enzymes, Nattokinase, and More

Seller of Cholesterol-Lowering Supplements Warned for Drug Claims